Viewing Study NCT04536350

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:06 PM
Ignite Modification Date: 2026-02-20 @ 4:49 PM
Study NCT ID: NCT04536350
Status: TERMINATED
Last Update Posted: 2024-01-18
First Post: 2020-08-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS
Sponsor: Prof. Dr. Jörg Leuppi
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid19 View
None Corona Virus Infection View
None ARDS View
None Aviptadil View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Covid 19 View
None Corona Virus Infection View
None acute respiratory distress syndrome (ARDS) View
None Aviptadil View
None Faster recovery View